The RIE2020 HBMS Vision is to be a leading centre that advances human health and wellness, and creates economic value for Singapore and Singaporeans, through the pursuit of excellence in research and its applications. 

For better focus, integration and sustainability in RIE2020, five therapeutic areas of focus have been identified by the Ministry of Health (MOH) as national priorities, based on factors such as disease impact, scientific excellence in Singapore and national needs. These are (i) cancers, (ii) cardiovascular diseases, (iii) diabetes mellitus and other metabolic / endocrine conditions, (iv) infectious diseases, and (v) neurological and sense disorders.  

For each of the five therapeutic areas, a Disease Taskforce was established. Each Taskforce developed research roadmaps to determine specific problem statements and priority areas within each of the five areas. These include pathways to translate research discoveries into healthcare solutions, innovative medicines or medical devices so as to create value.  

Please click the links below for the reports. 

1. Cancers 

   Executive Summary
   Summary Report

2. Cardiovascular Diseases 

   Executive Summary
   Summary Report 

3. Diabetes 

   Executive Summary
   Summary Report  

4. Infectious Diseases

   Executive Summary
   Summary Report

5. Neurological and Sense Disorders 

   Executive Summary
   Summary Report